Gordian Untangle Complex Disease
3 known investors
Gordian uses a proprietary in vivo drug discovery platform to identify therapeutic targets and treatments for complex age-related diseases. The company develops novel therapies with higher probability of clinical success.
AI & Machine LearningBiotechLongevity